NCT06590012: SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY
- State
- Under way
- Phase
- Phase 2
- People
- 1,228 taking part
- Started
- 29 Aug 2024
- Primary completion
- 15 Jul 2027
- Arms
- Tertinat
- Results
- None posted
- 29 Aug 2024: Trial started
- 19 Sep 2024: Trial registered